[Molecular determinants in osteoclast differentiation and osteoimmunology].
Takayanagi
Hiroshi
H
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D001842:Bone and Bones / Q000276:immunology*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000502:physiology; D056657:Cathepsin K / Q000037:antagonists & inhibitors / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics*; D017362:Cyclic AMP Response Element-Binding Protein / Q000502:physiology; D015195:Drug Design; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D050778:NFATC Transcription Factors / Q000502:physiology*; D010010:Osteoclasts / Q000166:cytology* / Q000276:immunology*; D053245:RANK Ligand / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D017362:Cyclic AMP Response Element-Binding Protein; D007375:Interleukin-1; D015850:Interleukin-6; D050778:NFATC Transcription Factors; D053245:RANK Ligand; D014409:Tumor Necrosis Factor-alpha; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D056657:Cathepsin K